World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT02100176
Date of registration: 24/03/2014
Prospective Registration: No
Primary sponsor: Ospedale Generale Di Zona Moriggia-Pelascini
Public title: MIRT and Rotigotine in the Early Stage of PD MIRT-RT
Scientific title: Multidisciplinary Intensive Rehabilitation Treatment and Rotigotine in the Early Stages of Parkinson's Disease: a Randomized Controlled Study.
Date of first enrolment: January 2013
Target sample size: 40
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT02100176
Study type:  Observational [Patient Registry]
Study design:  Observational Model: Cohort, Time Perspective: Prospective  
Phase:  N/A
Countries of recruitment
Italy
Contacts
Name:     Giuseppe Frazzitta, MD
Address: 
Telephone:
Email:
Affiliation:  Ospedale generale di Zona "Moriggia-Pelascini", Gravedona ed Uniti 22015 - CO, Italy
Name:     Giuseppe Frazzitta, MD
Address: 
Telephone: +39034492552
Email: frazzittag62@gmail.com
Affiliation: 
Key inclusion & exclusion criteria

Inclusion Criteria:

- Idiopathic Parkinson's disease according to Gelb et al., ability to walk without any
physical assistance, no cognitive impairment (MMSE score > 26), no comorbidity
unrelated to Parkinson's disease, no vestibular/visual dysfunction limiting locomotor
or balance.

Exclusion Criteria:

- Atypical Parkinsonisms, cognitive impairment (MMSE < 26), other comorbidities not
related to PD, vestibular/visual dysfunction limiting locomotor or balance.



Age minimum: 50 Years
Age maximum: 75 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Parkinson's Disease
Intervention(s)
Drug: Rotigotine
Other: Multidisciplinary intensive rehabilitation treatment
Primary Outcome(s)
UPDRS total score [Time Frame: 18 Months]
Secondary Outcome(s)
6MWT [Time Frame: 18 Months]
UPDRS II [Time Frame: 18 Months]
UPDRS III [Time Frame: 18 Months]
BBS [Time Frame: 18 Months]
CGS and FGS [Time Frame: 18 Months]
SPDDS [Time Frame: 18 Months]
TUG [Time Frame: 18 Months]
Secondary ID(s)
MIRT-RT
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history